Étude coût-efficacité de la vaccination pneumococcique chez les personnes âgées en France
- 31 August 2002
- journal article
- Published by Elsevier BV in Medecine Et Maladies Infectieuses
- Vol. 32 (8), 405-417
- https://doi.org/10.1016/s0399-077x(02)00393-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly peopleThe Lancet, 1998
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyAmerican Journal Of Medicine, 1997
- Bacteremia With Streptococcus pneumoniaeJAMA, 1996
- Pneumococcal Polysaccharide Vaccine EfficacyJAMA, 1993
- Pneumococcal bacteremia in Monroe County, New York.American Journal of Public Health, 1992
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineThe New England Journal of Medicine, 1991
- Pneumococcal VaccineJAMA, 1990
- The Clinical Effectiveness of Pneumococcal Vaccine in the ElderlyAnnals of Internal Medicine, 1988
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsThe New England Journal of Medicine, 1986
- Pneumococcal Vaccine Efficacy in Selected Populations in the United StatesAnnals of Internal Medicine, 1986